Hereditary hemorrhagic telangiectasia

Haematologica

Volumn 90, Issue 6, 2005, Pages 728-732

  McDonald, Jamie ^a,b   Bayrak Toydemir, Pinar ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b ARUP LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN RECEPTOR; ACTIVIN RECEPTOR LIKE KINASE 1; AMINOCAPROIC ACID; DANAZOL; ENDOGLIN; ETHINYLESTRADIOL PLUS NORETHISTERONE; IRON; SMAD PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANTIBIOTIC PROPHYLAXIS; ARTERIOVENOUS MALFORMATION; ARTIFICIAL EMBOLISM; AUTOSOMAL DOMINANT DISORDER; BLEEDING; BLOOD TRANSFUSION; CAUTERIZATION; CHROMOSOME 12; CHROMOSOME 9; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ECHOCARDIOGRAPHY; ENDOTHELIUM CELL; EPISTAXIS; FAMILY HISTORY; GASTROINTESTINAL HEMORRHAGE; GENE MUTATION; HUMAN; HUMIDIFIER; IRON THERAPY; LASER SURGERY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PREVALENCE; RENDU OSLER WEBER DISEASE; REVIEW; TELANGIECTASIA; TREATMENT PLANNING; VASCULAR SMOOTH MUSCLE;

ADULT; AGE OF ONSET; ANIMALS; ARTERIOVENOUS MALFORMATIONS; CHILD; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; MODELS, ANATOMIC; MUTATION; TELANGIECTASIA, HEREDITARY HEMORRHAGIC;

EID: 21244445353     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. Westermann CJ, Rosina AF, De Vries V, de Coteau PA. The prevalence and manifestations of hereditary hemorrhagic telangiectasia in the Afro-Caribbean population of the Netherlands Antilles: a family screening. Am J Med Genet 2003;116A:324-8.
2. Kjeldsen A, Vase P, Green A. Hereditary haemorrhaeic telangiectasia: a population-base study of prevalence and mortality in Danish patients. J Int Med 1999;245:31-9.
3. Plauchu H, Bideau A. Epidemiologie et constitution d'un registre de population a propos d'une concentration geographique d'une maladie hereditaire rare. Population 1984;39: 765-86
4. Dakeishi M, Shioya T, Wada Y, Shindo T, Otaka K, Manabe M, et al. Genetics epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mutat 2002;19:140-8.
5. McDonald MT, Papenberg KA, Ghosh S, Glatfelter AA, Biesecker BB, Helmbold EA, et al. A disease locus for hereditary haemorrhagic telangiectasia maps to chromosome 9q33-34. Nat Genet 1994;6:197-204.
6. Shovlin CL, Hughes JM, Tuddenham EG, Temperley I, Perembelon YF, Scott J, et al. A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3. Nat Genet 1994;6:205-9.
7. Johnson DW, Berg JN, Gallione CJ, McAllister KA, Wamer JP, Helmbold EA, et al. A second locus for hereditary hemorrhagic telangiectasia maps to chromosome 12. Genome Res 1995; 5:21-8.
8. Panchenko MP, Williams MC, Brody JS, Yu Q. Type I receptor serine-threonine kinase preferentially expressed in pulmonary blood vessels. Am J Physiol 1996;270:L547-58.
9. Gougos A, St Jacques S, Greaves A, O'Connell PJ, d'Apice AJ, Buhring HJ, et al. Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts. Int Immunol 1992; 4:83-92.
10. Barbara NP, Wrana JL, Letarte M. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta super-family. J Biol Chem 1999;274:584-94.
11. Attisano L, Carcamo J, Venture F, Weis FM, Massagué J, Wrana JL. Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes with type II receptors. Cell 1993;5:671-80.
12. Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, et al. TGFβ signals through a heteromeric protein kinase receptor complex. Cell 1992;71:1003-14.
13. Massagué J. TGF-β signal transduction. Annu Rev Biochem 1998;67:753-91.
14. Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, ten Dijke P. Balancing the activation state of the endothelium via two distinct TGF-β type I receptors. EMBO J 2002; 21:1743-53.
15. Goumans MJ, Valdimarsdottir G, Itoh S, Lebrin F, Larsson J, Mummery C, et al. Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFβ/ALK5 signaling. Mol Cell 2003;12:817-28.
16. Li DY, Sorensen LK, Brooke BS, Urness LD, Davis EC, Taylor DG, et al. Defective angiogenesis in mice lacking endoglin. Science 1999;284:1534-7.
17. Arthur HM, Ure J, Smith AJ, Renforth G, Wilson DI, Torsney E, et al. Endoglin, an ancillary TGFβ receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol 2000;217:42-53.
18. Umess LD, Sorensen LK, Li DY. Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Genet 2000; 26:328-31.
19. Bourdeau A, Dumont DJ, Letarte M. A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest 1999;104: 1343-51.
20. Srinivasan S, Hanes MA, Dickens T, Porteous ME, Oh SP, Hale LP, et al. A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2. Hum Mol Genet 2003;12:473-82.
21. Gallione CJ, Repetto GM, Legius E, Rustig AK, Schelley SL, Tejpar S, et al. A combined syndrome of juvenile polyposis with mutations in MADH4 (SMAD4). Lancet 2004;363:852-9.
22. Wallace G, Shovlin C. A hereditary haemorrhagic telangiectasia family with pulmonary involvement is unlinked to the known HHT genes, endoglin and ALK-1. Thorax 2000;55:685-90.
23. Cirulli A, Liso A, D'Ovidio F, Mestice A, Pasculli G, Gallitelli M, et al. Vascular endothelial growth factor serum levels are elevated in patients with hereditary hemorrhagic telangiectasia. Acta Haematol 2003;110:29-32.
24. Xu B, Wu YQ, Huey M, Arthur HM, Marchuk DA, Hashimoto T, et al. Vascular endothelial growth factor induces abnormal microvasculature in the endoelin heterozygous mouse brain. J Cereb Blood Flow Metab 2004;24:237-44.
25. Bayrak-Toydemir P, Mao R, Lewin S, McDonald J. Hereditary haemorrhagic telangiectasia: an overview of diagnosis and management in the molecular era for clinicians. Genet in Med 2004;6:175-191.
26. Assar A, Friedman C, White R. The natural history of epistaxis in hereditary hemorrhagic telangiectases. Laryngoscope 1991; 101:977-80.
27. Plauchu H, de Chadarevian JP, Bideau A, Robert JM. Age-related clinical profile of hereditary haemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet 1989;32:291-7.
28. Porteous M, Bum J, Proctor S. Hereditary haemorrhagic tlenagiectasia: a clinical analysis. J Med Genet 1992;29:527-30.
29. Kjeldsen A, Kjeldsen J. Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia. Am J Gastroenterology 2000;95:415-8.
30. Haitjema T, Disch F, Overtoom T, Westermann C, Lammers J. Screening family members of patients with hereditary hemorrhagic telangiectasia. Am J Med 1995;99:519-24.
31. Kjeldsen A, Oxhoj H, Andersen P, Green A, Vase P. Prevalence of pulmonary arteriovenous malformations (PAVMs) and occurrence of neurological symptoms in patients with hereditary haemorrhagic telangiectasia (HHT). J Int Med 2000;248: 255-62.
32. Vase P, Holm M, Arendrup H. Pulmonary arteriovenous fistulas in herditary hemorrhagic telangiectasia. Acta Med Scand 1985;218:105-9.
33. Shovlin C, LeTarte M. Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms. Thorax 1999;54:714-29.
34. White, R. Pulmonary arterioveous malformations: how do we diagnoses them and why is it important to do so? Radiology 1992;182:633-5.
35. Ference B, Shannon T, White R, Zawin M, Burdge C. Life-threatening pulmonary hemorrhage with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia. Chest 1994;106:1387-90.
36. Moussouttas M, Fayad P, Rosenblatt M, Hashimoto M, Pollak J, Henderson K, et al. Pulmonary arteriovenous malformations: cerebral ischemia and neurologic manifestations. Neurology 2000;55:959-64.
37. White R, Pollak J, Wirth J. Pulmonary arteriovenous malformations: diagnosis and transcatheter embolotherapy. J Vasc Interv Radiol 1996;7:787-804.
38. Hewes, R, Auster M, White R. Cerebral embolism: first manifestation of pulmonary arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia. Cardiovasc Inter Rad 1985;8:151-5.
39. Shovlin C, Winstock A, Peters A, Jackson J, Hughes J. Medical complications of pregnancy in hereditary hemorrhagic telangiectasia. Q J Med 1995;88:879-87.
40. Fulbright R, Chaloupka J, Putman C, Sze G, Merriam M, Lee G, et al. MR of hereditary hemorrhagic telangiectasia: prevalence and spectrum of cerebrovascular malformations. Am J Neurol Radiol 1998;19:477-84.
41. Matsubara S, Manzia J, ter Brugge K, Willinsky R, Montanera W, Faughnan M. Angiographic and clinical characteristics of patients with cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia. Am J Neuroradiology 2000;21:1016-20.
42. Willemse R, Mager J, Westermann C, Overtoom T, Mauser H, Wolbers J. Bleeding risk of cerebrovascular malformation in hereditary hemorrhagic telangiectasia. J Neurosurg 2000;92: 779-84.
43. Morgan T, McDonald J, Anderson C, Ismail M, Miller F, Mao R, et al. Intracranial hemorrhage in infants and children with hereditary hemorrhagic telangiectasia. Pediatrics 2002;109:1-7.
44. Mont'Alverne F, Musacchio M, Tolentino V, Belzile F, Riquelme C, Toumade A. Giant spinal perimedullary fistula in hereditary haemorrhagic telangiectasia: diagnosis, endovascular treatment and review of the literature. Neuroradiology 2003; 45:830-6.
45. Garcia-Tsao G, Korzenik J, Young L, Henderson K, Jain D, Byrd B, et al. Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2000;343:931-6.
46. Memeo M, Stabile Ianora AA, Scardapane A, Buonamico P, Sabba C, Angeleui G. Hepatic involvement in hereditary hemorrhagic telangiectasia. Abdom Imaging 2004;29:211-20.
47. Stabile Ianora AA, Memeo M, Sabba C, Cirulli A, Rotondo A, Angelelli G. Hereditary hemorrhagic telangiectasia: multidetector row helical T assessment. Radiology 2004;23:250-9.
48. Saluja S, White RI. Hereditary hemorrhagic telangiectasia of the liver; hyperperfusion with relative ischemia: poverty amidst plenty? Radiology 2004;230:25-7.
49. His DH, Ryan GF, Hellems SO Cheeran DC, Shells LA. Large aneurysms of the ascending aorta and major coronary arteries in a patient with hereditary hemorrhagic telangiectasia. Mayo Clin Proc 2003;78:774-6.
50. Tsuiki K, Tamada Y, Yasui S. Coronary artery aneurysm without stenosis in association with Osler-Weber-Rendu disease- a case report. Angiology 1991;42:55-8.
51. Brant A, Schachat A, White R. Ocular manifestations in hereditary hemorrhagic telangiectasia. Am J Ophthalmol 1989;107: 642-6.
52. Vase I, Vase P. Ocular lesions in hereditary hemorrhagic telangiectasia. Acta Ophthalmol 1979;57:1084-90.
53. Lande A, Bedford A, Schechter LS. The spectrum of arteriographic findings in Osler-Weber- Rendu disease. Angiology 1976;27:223-40.
54. Ziani M, Valignat C, Lopez J, Ruffion A, Plauchu H, Perrin P. Renal arteriovenous malformation requiring surgery in Rendu-Osler-Weber disease. J Urology 2000;164:1292-3.
55. Humphries JE, Frierson HF Jr, Underwood PB Jr. Vaginal telangiectasias: unusual presentation of the Osler-Weber-Rendu syndrome. Obstet Gynecol 1993;81:865-6.
56. Trembath RC, Thomson JR, Machado RD, Morgan NV, Atkinson C, Winship I, et al. Clinical and molecular genetic features of pulmonary hypertension in patients with nereditary hemorrhagic telangiectasia. N Engl J Med 2001;345:325-34.
57. Shovlin C, Guttmacher A, Buscarini E, Faughnan M, Hyland R, Westermann C, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber Syndrome). Am J Med Genet 2000;91:66-7.
58. Nanthakumar K, Graham A, Robinson T, Grande P, Pugash R, Clarke J, et al. Contrast echocardiography for detection of pulmonary arteriovenous malformations. Am Heart J 2001;141: 243-6.
59. Remy J, Remy-Jardin M, Wattinne L, Deffontaines C. Pulmonary arteriovenous malformations: evaluation with CT of the chest before and after treatment. Radiology 1992;182:809-16.
60. White R, Pollak J. Pulmonary arteriovenous malformations: diagnosis with three-dimensional helical CT- a breakthrough without contrast media. Radiology 1994;191:613-4.
61. Lee D, White R, Egglin T, Pollak J, Fayad P, Wirth J, et al. Embolotherapy of large pulmonary arteriovenous malformations: lone-term results. Ann Thorac Surg 1997;64:930-40.
62. Levy EI, Niranjan M, Thompson T, Scarrow A, Kondziolka D, Flickinger J, Lunsford L. Radiosurgery for childhood intracranial arteriovenous malformations. Neurosurgery 2000;47:834-42.
63. Vinuela F, Dion J, Duckwiler G, Martin N, Lylyk P, Fox A, et al. Combined endovascular embolization and surgery in the management of cerebral arteriovenous malformations: experience with 101 cases. J Neurosurg 1991;75:856-64.
64. Kondziolka D, Humphreys R, Hoffman H, Hendrick EB, Drake J. Arteriovenous malformations of the brain in children: a forty year experience. Can J Neurol Sci 1992;19:40-5.
65. Odorico J, Hakim M, Becker Y. Liver transplantation as definitive therapy for complication after arterial embolization for hepatic manifestations of hereditary hemorrhagic telangiectasia. Liver Transpl Surg 1998;4:483-90.
66. Miller F, Whiting J, Korzenik J, White R. Caution with use of hepatic embolization in the treatment of hereditary hemorrhagic telangiectasia. Radiology 1999;213:928-30.
67. Boiflot O, Bianco F, Viale J. Liver transplantation resolves the typerdynamic circulation in hereditary nemorrhagic telangiectasia with hepatic involvement. Gastroenterology 1999;116: 187-92.
68. Parkin J, Dixon JA. Laser photocoagulation in hereditary hemorrhagic telangiectasia. Otolaryngol Head Neck Surg 1981;89: 204-8.
69. Shapshay S, Oliver P. Treatment of hereditary hemorrhagic telangiectasia by Nd-Yag laser photocoagulation. Laryngoscope 1984;94:1554-6.
70. Saunders, W. Septal dermoplasty for control of nosebleeds caused by hereditary hemorrhagic telangiectasia or septal perforations. Trans Am Acad Ophthalmol Otolaryngol 1960;64: 500-6.
71. Longacre A, Gross C, Gallitelli M, Henderson K, White R, Proctor D. Diagnosis and management of gastrointestinal bleeding in patient with hereditary hemorrhagic telangiectasia. Am J Gastroenterology 2003;98:59-65.
72. Berg J, Guttmacher A, Marchuk D, Porteous M. Clinical heterogeneity in hereditary hemorrhagic telangiectasia: are pulmonary arteriovenous malformation more common in families linked to endoglini J Med Genet 1996;33:256-7.
73. Heutink P, Haitjema T, Breedveld G, Janssen B, Sandkuijl L, Bontekoe C, et al. Linkage of hereditary haemorrhagic telangiectasia to chromosome 9q34 and evidence for locus heterogeneity. J Med Genet 1994;31:933-6.
74. Buscarini E, Buscarini L, Danesino C, Pinatanida M, Civardi G, Quaretti P, et al. Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: Doppler sonographic screening in a large family. J Hepatol 1997;26:111-8.
75. McDonald J, Miller F, Hallam S, Nelson L, Marchuk D, Ward K. Clinical manifestations in a large hereditary hemorrhagic telangiectasia type 2 kindred. Am J Med Genet 2000;93:320-7.
76. Olivieri C, Mira E, Delu G, Pagella F, Zambelli A, Malvezzi L, et al. Identification of 13 new mutations in the ACVRL1 gene in a group of 52 unselected Italian patients affected by hereditary haemorrhagic telangiectasia. J Med Genet 2002;39:E39.
77. Abdalla S, Geisthoff U, Bonneau D, Plauchu H, McDonald J, Kennedy S, et al. Visceral manifestations in hereditary haemorrhagic telangiectasia type 2. J Med Genet 2003;40:494-502.